- Home
- TRML vs NML Comparison
TRML vs NML Comparison
Compare TRML & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- NML
- Stock Information
- Founded
- TRML 2021
- NML 2012
- Country
- TRML United States
- NML United States
- Employees
- TRML N/A
- NML N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- NML Finance/Investors Services
- Sector
- TRML Health Care
- NML Finance
- Exchange
- TRML Nasdaq
- NML Nasdaq
- Market Cap
- TRML 509.8M
- NML 517.3M
- IPO Year
- TRML N/A
- NML N/A
- Fundamental
- Price
- TRML $13.84
- NML $9.15
- Analyst Decision
- TRML Strong Buy
- NML
- Analyst Count
- TRML 6
- NML 0
- Target Price
- TRML $45.20
- NML N/A
- AVG Volume (30 Days)
- TRML 360.6K
- NML 219.3K
- Earning Date
- TRML 03-13-2025
- NML 01-01-0001
- Dividend Yield
- TRML N/A
- NML 9.75%
- EPS Growth
- TRML N/A
- NML N/A
- EPS
- TRML N/A
- NML N/A
- Revenue
- TRML N/A
- NML N/A
- Revenue This Year
- TRML $363.93
- NML N/A
- Revenue Next Year
- TRML N/A
- NML N/A
- P/E Ratio
- TRML N/A
- NML N/A
- Revenue Growth
- TRML N/A
- NML N/A
- 52 Week Low
- TRML $11.87
- NML $6.09
- 52 Week High
- TRML $29.79
- NML $7.33
- Technical
- Relative Strength Index (RSI)
- TRML 37.41
- NML 59.40
- Support Level
- TRML $16.39
- NML $8.94
- Resistance Level
- TRML $17.36
- NML $9.20
- Average True Range (ATR)
- TRML 1.03
- NML 0.16
- MACD
- TRML -0.35
- NML 0.03
- Stochastic Oscillator
- TRML 1.72
- NML 90.57
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States.